a new healthcare research company 
 
 

Access to Defibrotide (Global)

Healthcare professionals outside of the U.S. and Italy may be able to obtain Defibrotide via a named patient use program by contacting IDIS at +44 (0) 1932 824 100 or by sending an e-mail to globalsales@idispharma.com.

IDIS has a proven track record in the development and implementation of Named Patient Programs. IDIS supports its customers in over 100 countries worldwide, supplying more than 400 different medicines per month and responding to more than half a million requests on a named patient basis to medical professionals worldwide. Headquartered near central London, IDIS has been a strategic partner to more than 40 pharmaceutical and biotech companies.

www.idispharma.com

 

 
DEFIBROTIDE HEPARIN UROKINASE SULGLICOTIDE